Skip Nav Destination
Distinguishing the type I and type II isozymes of hexokinase: the need for a reexamination of past practice.
Diabetes October 1998, Vol.47, 1544-1548. doi:https://doi.org/10.2337/diabetes.47.10.1544
Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
Topics: epinephrine , insulin , mitogen-activated protein kinases , signal pathway , signal transduction pathways
Diabetes October 1998, Vol.47, 1549-1554. doi:https://doi.org/10.2337/diabetes.47.10.1549
Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
Diabetes October 1998, Vol.47, 1555-1561. doi:https://doi.org/10.2337/diabetes.47.10.1555
Diabetes October 1998, Vol.47, 1562-1569. doi:https://doi.org/10.2337/diabetes.47.10.1562
Diabetes October 1998, Vol.47, 1570-1577. doi:https://doi.org/10.2337/diabetes.47.10.1570
Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
Diabetes October 1998, Vol.47, 1578-1585. doi:https://doi.org/10.2337/diabetes.47.10.1578
Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
Diabetes October 1998, Vol.47, 1586-1593. doi:https://doi.org/10.2337/diabetes.47.10.1586
Diabetes October 1998, Vol.47, 1594-1601. doi:https://doi.org/10.2337/diabetes.47.10.1594
Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
Topics: ciliary neurotrophic factor , endocrine pancreas , interleukin-1 beta , nitric oxide , nitric oxide synthase
Diabetes October 1998, Vol.47, 1602-1608. doi:https://doi.org/10.2337/diabetes.47.10.1602
Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
Diabetes October 1998, Vol.47, 1613-1618. doi:https://doi.org/10.2337/diabetes.47.10.1613
Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
Diabetes October 1998, Vol.47, 1619-1624. doi:https://doi.org/10.2337/diabetes.47.10.1619
Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
M D'Adamo; A Buongiorno; E Maroccia; F Leonetti; F Barbetti; A Giaccari; D Zorretta; G Tamburrano; P Sbraccia
Diabetes October 1998, Vol.47, 1625-1629. doi:https://doi.org/10.2337/diabetes.47.10.1625
Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
J C Parker; M A VanVolkenburg; C B Levy; W H Martin; S H Burk; Y Kwon; C Giragossian; T G Gant; P A Carpino; R K McPherson; P Vestergaard; J L Treadway
Diabetes October 1998, Vol.47, 1630-1636. doi:https://doi.org/10.2337/diabetes.47.10.1630
Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
Diabetes October 1998, Vol.47, 1637-1642. doi:https://doi.org/10.2337/diabetes.47.10.1637
E Bonora; S Kiechl; J Willeit; F Oberhollenzer; G Egger; G Targher; M Alberiche; R C Bonadonna; M Muggeo
Diabetes October 1998, Vol.47, 1643-1649. doi:https://doi.org/10.2337/diabetes.47.10.1643
Diabetes October 1998, Vol.47, 1654-1656. doi:https://doi.org/10.2337/diabetes.47.10.1654
Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
Diabetes October 1998, Vol.47, 1657-1658. doi:https://doi.org/10.2337/diabetes.47.10.1657